识别肿瘤患者椎体骨髓转移性疾病中最显著的磁共振成像(MRI)影像组学特征:一项可行性研究
本研究纳入8例肿瘤患者共58个胸椎椎体(29个转移、29个非转移),在T1和T2加权图像上提取89个影像组学特征,采用Wilcoxon检验和逐步特征选择构建逻辑回归模型。最佳模型在T2图像上由形态学特征(质心偏移)和纹理特征(灰度共生矩阵联合方差)组成,内部交叉验证AUC为0.9116(95%CI 0.8294-0.9937),T1图像AUC为0.8141(95%CI 0.6854-0.9427)。
要点
- T2图像上质心偏移与灰度共生矩阵联合方差构建的模型区分转移与非转移椎体AUC达0.9116。
- T1图像上质心偏移与最小灰度级构建的模型AUC为0.8141(95%CI 0.6854-0.9427)。
- 89个特征中有16个在转移与非转移组间差异有统计学意义。
核心结论
- 基于MRI的影像组学分析似乎能够区分肿瘤患者的转移性与非转移性椎体,最显著的预测特征基于T2序列,包括一个形态学特征和一个纹理特征。
研究设计与样本
- 可行性研究,纳入8例肿瘤患者(3例肺癌、1例前列腺癌、1例食管癌、1例鼻咽癌、1例肝癌、1例乳腺癌)放疗前MRI,共58个胸椎椎体(29个转移、29个非转移),在放疗勾画工作站于T1和T2加权图像上勾画每个椎体,提取89个形态学、统计和纹理特征(取每层中位数),采用Wilcoxon检验和逐步特征选择构建逻辑回归模型,并通过bootstrap进行内部交叉验证评估AUC。
诊断标准与关键数值
- T1图像模型含质心偏移(p值<0.01)和最小灰度级(p值<0.01),内部交叉验证AUC为0.8141(95%CI 0.6854-0.9427);T2图像模型含质心偏移(p值<0.01)和灰度共生矩阵联合方差(p值<0.01),内部交叉验证AUC为0.9116(95%CI 0.8294-0.9937);89个纹理特征中16个在转移与非转移组间差异有统计学意义。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Recently, radiomic analysis has gained attention as a valuable instrument for the management of oncological patients. The aim of the study is to isolate which features of magnetic resonance imaging (MRI)-based radiomic analysis have to be considered the most significant predictors of metastasis in oncological patients with spinal bone marrow metastatic disease.
MATERIALS AND METHODS: Eight oncological patients (3 lung cancer; 1 prostatic cancer; 1 esophageal cancer; 1 nasopharyngeal cancer; 1 hepatocarcinoma; 1 breast cancer) with pre-radiotherapy MR imaging for a total of 58 dorsal vertebral bodies, 29 metastatic and 29 non-metastatic were included. Each vertebral body was contoured in T1 and T2 weighted images at a radiotherapy delineation console. The obtained data were transferred to an automated data extraction system for morphological, statistical and textural analysis. Eighty-nine features for each lesion in both T1 and T2 images were computed as the median of by-slice values. A Wilcoxon test was applied to the 89 features and the most statistically significant of them underwent to a stepwise feature selection, to find the best performing predictors of metastasis in a logistic regression model. An internal cross-validation via bootstrap was conducted for estimating the model performance in terms of the area under the curve (AUC) of the receiver operating characteristic.
RESULTS: Of the 89 textural features tested, 16 were found to differ with statistical significance in the metastatic vs non-metastatic group. The best performing model was constituted by two predictors for T1 and T2 images, namely one morphological feature (center of mass shift) (p value < 0.01) for both datasets and one histogram feature minimum grey level (p value < 0.01) for T1 images and one textural feature (grey-level co-occurrence matrix joint variance (p value < 0.01) for T2 images. The internal cross-validation showed an AUC of 0.8141 (95% CI 0.6854-0.9427) in T1 images and 0.9116 (95% CI 0.8294-0.9937) in T2 images.
CONCLUSIONS: The results suggest that MRI-based radiomic analysis on oncological patients with bone marrow metastatic disease is able to differentiate between metastatic and non-metastatic vertebral bodies. The most significant predictors of metastasis were found to be based on T2 sequence and were one morphological and one textural feature.
引用
- Filograna L, Lenkowicz J, Cellini F, et al. Identification of the most significant magnetic resonance imaging (MRI) radiomic features in oncological patients with vertebral bone marrow metastatic disease: a feasibility study. Radiol Med. 2018. PMID: 30191445. doi:10.1007/s11547-018-0935-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。